The American Society of Nuclear Cardiology (ASNC) has shared its official answer to a decades-long debate over which cardiac nuclear imaging modality is the best for evaluating heart patients. In a new position statement, the group officially recommended that cardiac positron emission tomography (PET), if available, be used to evaluate all patients with suspected coronary artery disease (CAD) who are candidates for myocardial perfusion imaging (MPI). The statement was published in full in the Journal of Nuclear Cardiology.[1]
1. Timothy M. Bateman, Mouaz H. Al-Mallah, Talal S. Alnabelsi, Parthiban Arumugam, Dennis A. Calnon, Panithaya Chareonthaitawee, Marcelo Di Carli, Gary V. Heller, Prem Soman. Clinical Indications for PET Myocardial Perfusion Imaging and Myocardial Blood Flow Quantification: An American Society of Nuclear Cardiology (ASNC) Position Statement. Journal of Nuclear Cardiology. 102619. Dec. 31, 2025.
Related Posts
